Earningsreport

Q3/2023 9/30/2023 EPS -0.110 ZacksConsensus -0.120 ActVsEst 0.010 - Beat

VolitionRX Limited  (VNRX) 
NASDAQ:AMEX Investor Relations: ir.volitionrx.com